Otrexup is a single-dose auto-injector containing a prescription medicine, methotrexate
Otrexup is indicated in certain adults with severe, active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis (pJIA) and adults with severe, resistant, disabling psoriasis
Otrexup should not be used for the treatment of cancer
Otrexup should not be used for the treatment of children with psoriasis
Fixed volume for all doses (0.4 mL)
Uses 27 gauge, 1/2 inch needle which is never visible (exposed needle length 2.5 - 5 mm)
Manufacturer # 54436001504
Brand Otrexup™
Manufacturer Antares Pharma Inc
Country of Origin Germany
Application Antineoplastic Agent
Container Type Prefilled Auto-Injector
Dosage Form Injection
Generic Drug Code 35428
Generic Drug Name Methotrexate, Preservative Free
Is_Active_Vendor Y
Is_DSCSA Y
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 54436001504
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Quantity 4 Devices
Strength 15 mg / 0.4 mL
Supplier_ID 3885243
Type Subcutaneous
UNSPSC Code 51111610
